112P Patients’ knowledge about ductal carcinoma in situEllen G. Engelhardt, Eveline M. A. Bleiker, E. Verschuur-van der Voort et al.|Annals of Oncology|2022Cited by 0
The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safeRenée Schmitz, J. Wesseling, C. Sondermeijer et al.|European Journal of Cancer|2022Cited by 0